ScienceOpen:
research and publishing network
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
My ScienceOpen
Sign in
Register
Dashboard
Blog
About
Search
Advanced search
My ScienceOpen
Sign in
Register
Dashboard
Search
Search
Advanced search
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
Blog
About
3
views
0
references
Top references
cited by
36
0 reviews
Review
0
comments
Comment
0
recommends
+1
Recommend
0
collections
Add to
0
shares
Share
Twitter
Sina Weibo
Facebook
Email
2,891
similar
All similar
Record
: found
Abstract
: not found
Book
: not found
China guidelines for pharmacoeconomic evaluations.
Author(s):
G LIU
,
S. HU
,
J Wu
,
GG Liu
,
G. Liu
,
S Hu
,
SL HU
,
JH Wu
,
GE Liu
,
, Liu
,
S. S. Hu
,
J. Q. WU
,
Z. DONG
,
H Li
,
GGHS Liu
,
L Yang
,
HC Li
,
Z Dong
,
H. Li
,
C Dong
,
H Shanlian
,
HS Liu G
,
G. Liu
,
C. F. Dong
,
M.-H. Li
,
SL Hu
,
ZH Dong
,
Liu GG.
Publication date:
2020
Read this book at
Bookmark
There is no author summary for this book yet. Authors can add summaries to their books on ScienceOpen to make them more accessible to a non-specialist audience.
Related collections
China Occupational Medicine
Data availability:
Comments
Comment on this book
Sign in to comment
Similar content
2,891
Pharmacoeconomic evaluation model for relapsed or refractory B-cell acute lymphoblastic leukemia therapies: a systematic review (in Chinese)
Authors:
L Yang
,
R Meng
,
A. MA
Pharmacoeconomics evaluation of shenqi Fuzheng injection combined with chemotherapy for non-small cell lung cancer.
Authors:
X Liu
,
X. ZHANG
,
W. HUANG
…
Pharmacoeconomic Analyses Using Discrete Event Simulation
Authors:
J Caro
See all similar
Cited by
36
Cost-Effectiveness Analysis of Camrelizumab Plus Chemotherapy vs. Chemotherapy Alone as the First-Line Treatment in Patients With IIIB–IV Non-Squamous Non-Small Cell Lung Cancer (NSCLC) Without EGFR and ALK Alteration from a Perspective of Health - Care System in China
Authors:
Chen Zhu
,
Xiao-xuan Xing
,
Bin Wu
…
Population Norms for SF-6Dv2 and EQ-5D-5L in China.
Authors:
Shitong Xie
,
Jing Wu
,
Feng Xie
Cost-effectiveness analysis of nivolumab combination therapy in the first-line treatment for advanced esophageal squamous-cell carcinoma
Authors:
Shixian Liu
,
Lei Dou
,
Kaixuan Wang
…
See all cited by